PubMed

The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes.

Gillespie EL, White CM, Kardas M, Lindberg M, Coleman CI.

Diabetes Care. 2005 Sep;28(9):2261-6.PMID: 16123505 [PubMed - indexed for MEDLINE]Related articlesFree article

The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.

Kuti EL, Baker WL, White CM.

Curr Med Res Opin. 2007 Jun;23(6):1239-44. Epub 2007 Apr 23.PMID: 17559720 [PubMed - indexed for MEDLINE]Related articles

Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials).

Andraws R, Brown DL.

Am J Cardiol. 2007 Apr 1;99(7):1006-12. Epub 2007 Feb 16.PMID: 17398202 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular outcomes in high-risk patients without heart failure treated with ARBs: a systematic review and meta-analysis.

Al Khalaf MM, Thalib L, Doi SA.

Am J Cardiovasc Drugs. 2009;9(1):29-43. doi: 10.2165/00129784-200909010-00004. Review.PMID: 19178130 [PubMed - indexed for MEDLINE]Related articles

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

Weir MR.

Clin Ther. 2007 Sep;29(9):1803-24. Review.PMID: 18035185 [PubMed - indexed for MEDLINE]Related articles

Effect of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset diabetes mellitus: a review and pooled analysis.

McCall KL, Craddock D, Edwards K.

Pharmacotherapy. 2006 Sep;26(9):1297-306. Review.PMID: 16945052 [PubMed - indexed for MEDLINE]Related articles

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.

Abuissa H, Jones PG, Marso SP, O'Keefe JH Jr.

J Am Coll Cardiol. 2005 Sep 6;46(5):821-6.PMID: 16139131 [PubMed - indexed for MEDLINE]Related articles

The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials.

Madrid AH, Peng J, Zamora J, Marín I, Bernal E, Escobar C, Muños-Tinoco C, Rebollo JM, Moro C.

Pacing Clin Electrophysiol. 2004 Oct;27(10):1405-10.PMID: 15511250 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.

Kunz R, Friedrich C, Wolbers M, Mann JF.

Ann Intern Med. 2008 Jan 1;148(1):30-48. Epub 2007 Nov 5.PMID: 17984482 [PubMed - indexed for MEDLINE]Related articlesFree article

Do ACE Inhibitors/Angiotensin II type 1 receptor antagonists reduce hospitalisations in older patients with heart failure? A propensity analysis.

Trewet CB, Shireman TI, Rigler SK, Howard PA.

Drugs Aging. 2007;24(11):945-55.PMID: 17953461 [PubMed - indexed for MEDLINE]Related articles

Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.

Scheen AJ.

Diabetes Metab. 2004 Dec;30(6):487-96. Review.PMID: 15671918 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.

Yokoyama K, Yang W, Preblick R, Frech-Tamas F.

J Manag Care Pharm. 2007 Apr;13(3):235-44.PMID: 17407390 [PubMed - indexed for MEDLINE]Related articlesFree article

Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes.

Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME.

J Hypertens. 2005 Mar;23(3):463-73. Review.PMID: 15716683 [PubMed - indexed for MEDLINE]Related articles

Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.

Scheen AJ.

Drugs. 2004;64(22):2537-65. Review.PMID: 15516153 [PubMed - indexed for MEDLINE]Related articles

Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis.

Jennings DL, Kalus JS, Coleman CI, Manierski C, Yee J.

Diabet Med. 2007 May;24(5):486-93. Epub 2007 Mar 15.PMID: 17367311 [PubMed - indexed for MEDLINE]Related articles

Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials.

Lakhdar R, Al-Mallah MH, Lanfear DE.

J Card Fail. 2008 Apr;14(3):181-8. Review.PMID: 18381180 [PubMed - indexed for MEDLINE]Related articles

Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease.

Strippoli GF, Bonifati C, Craig M, Navaneethan SD, Craig JC.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006257. Review.PMID: 17054288 [PubMed - indexed for MEDLINE]Related articles

Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.

Coleman CI, Makanji S, Kluger J, White CM.

Ann Pharmacother. 2007 Mar;41(3):433-7. Epub 2007 Mar 6.PMID: 17341525 [PubMed - indexed for MEDLINE]Related articles

Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.

[No authors listed]

Prescrire Int. 2005 Oct;14(79):180-6.PMID: 16285075 [PubMed - indexed for MEDLINE]Related articles

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.

Matchar DB, McCrory DC, Orlando LA, Patel MR, Patel UD, Patwardhan MB, Powers B, Samsa GP, Gray RN.

Ann Intern Med. 2008 Jan 1;148(1):16-29. Epub 2007 Nov 5. Review.PMID: 17984484 [PubMed - indexed for MEDLINE]Related articlesFree article